Issue 11/2023
Content (8 Articles)
Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis
Nadine Bittner, Cleo S. M. Funk, Alexander Schmidt, Felix Bermpohl, Eva J. Brandl, Engi E. A. Algharably, Reinhold Kreutz, Thomas G. Riemer
Systematic Review and Meta-analysis of Interventions to Reduce Adverse Drug Reactions in Older Adults: An Update
Shelly L. Gray, Subashan Perera, Tim Soverns, Joseph T. Hanlon
Discontinuation of Loop Diuretics in Older Patients with Chronic Stable Heart Failure: A Narrative Review
Chukwuma Okoye, Tessa Mazzarone, Cristina Cargiolli, Daniela Guarino
Anti-VEGF Drugs in Age-Related Macular Degeneration: A Focus on Dosing Regimen-Related Safety and Efficacy
Haibei Ma, Hai Wei, Chunpu Zou, Guoqin Zhu, Qi Gao, Ning Zhang, Bing Wang
Methodological Considerations for Describing Medication Changes in Relation to Clinical Events and Death: An Applied Example in Patients with Type 2 Diabetes and Cancer
Karl Sebastian Johansson, Tonny Studsgaard Petersen, Mikkel Bring Christensen, Anton Pottegård
Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales
Alessio Novella, Chiara Elli, Aladar Ianes, Luca Pasina
Five-Year Follow-Up of Diabetic Complications and Geriatric Alterations in French Older Patients with Type 2 Diabetes According to Treatment Modalities: The Observational Prospective GERODIAB Cohort
Jean Doucet, Olivia Guérin, Caroline Hilbert, Lyse Bordier, Julien Wils, Jacques Bénichou, Bernard Bauduceau
The PROMISING Project: A Pilot Study to Improve Geriatric Care Through a Pharmacist-Led Psychotropic Stewardship Program
Marie d’Amours, Farah Ettis, Lauriane Ginefri, Johnny Lim, Angela-Sinlan Lin Poo Yuan, Jennifer Fontaine, Dana Wazzan, David Williamson, Vincent Dagenais-Beaulé